Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Harmony Biosciences Holdings Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 21, 2021 / 07:20PM GMT
Release Date Price: $31.97 (+2.11%)
Daniil V. Gataulin
Raymond James & Associates, Inc., Research Division - Senior Research Associate

All right. Good afternoon, and welcome to the Raymond James Human Health Innovation Conference. My name is Daniil Gataulin, one of the members of the biotech research team here at Raymond James.

It's my pleasure to introduce John Jacobs, President and Chief Executive Officer; and Sandip Kapadia, Chief Financial Officer, who are joining us for a fireside chat from Harmony Biosciences. John and Sandip, welcome, and thank you for joining.

John Charles Jacobs
Harmony Biosciences Holdings, Inc. - President, CEO & Director

Thank you, Daniil. Appreciate it. Glad to be here with you.

Questions & Answers

Daniil V. Gataulin
Raymond James & Associates, Inc., Research Division - Senior Research Associate

Thank you. Before we dive deeper into your programs, it would be helpful for those of us new to the story to hear an overview of your company and your team. Can you spend a few minutes to tell us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot